FABP4 and type 2 diabetes mellitus: Decreasing FABP4 levels is also associated with augmented cardiomyocyte pathology and improved ventricular function in diabetic mouse models, with the increased FABP4 levels seen in type II diabetes potentially the cause of diabetic-induced cardiomyopathy [45].